NO992197D0 - FremgangsmÕte for Õ behandle bronkitt med uridintrifosfater og relaterte forbindelser - Google Patents
FremgangsmÕte for Õ behandle bronkitt med uridintrifosfater og relaterte forbindelserInfo
- Publication number
- NO992197D0 NO992197D0 NO992197A NO992197A NO992197D0 NO 992197 D0 NO992197 D0 NO 992197D0 NO 992197 A NO992197 A NO 992197A NO 992197 A NO992197 A NO 992197A NO 992197 D0 NO992197 D0 NO 992197D0
- Authority
- NO
- Norway
- Prior art keywords
- uridine
- bronchi
- clearance
- bronchioles
- utp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/744,367 US6159952A (en) | 1996-11-07 | 1996-11-07 | Method of treating bronchitis with uridine triphosphate and related compounds |
| PCT/US1997/018766 WO1998019685A1 (en) | 1996-11-07 | 1997-10-21 | Method of treating bronchitis with uridine triphosphates and related compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO992197D0 true NO992197D0 (no) | 1999-05-05 |
| NO992197L NO992197L (no) | 1999-07-05 |
Family
ID=24992452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO992197A NO992197L (no) | 1996-11-07 | 1999-05-05 | FremgangsmÕte for behandling av bronkitt med uridintrifosfater og relaterte forbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6159952A (no) |
| EP (1) | EP0941099B1 (no) |
| JP (1) | JP2001505553A (no) |
| KR (1) | KR100518066B1 (no) |
| CN (1) | CN1115152C (no) |
| AT (1) | ATE249833T1 (no) |
| AU (1) | AU744981B2 (no) |
| BR (1) | BR9714312A (no) |
| CA (1) | CA2271126C (no) |
| DE (1) | DE69724991T2 (no) |
| ES (1) | ES2207723T3 (no) |
| NO (1) | NO992197L (no) |
| NZ (1) | NZ335540A (no) |
| WO (1) | WO1998019685A1 (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
| US5968913A (en) * | 1996-07-03 | 1999-10-19 | Inspire Pharmaceuticals, Inc. | Pharmaceutical compositions of uridine triphosphate |
| US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
| US6872710B2 (en) * | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
| TW593331B (en) | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
| EP1012154B1 (en) | 1997-07-25 | 2004-03-17 | Inspire Pharmaceuticals, Inc. | Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| US6251693B1 (en) | 1998-07-30 | 2001-06-26 | Micron Technology, Inc. | Semiconductor processing methods and semiconductor defect detection methods |
| AU3612600A (en) * | 1999-02-26 | 2000-09-14 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
| US6867199B2 (en) | 2000-08-21 | 2005-03-15 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapeutic use |
| US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
| US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
| US6555675B2 (en) | 2000-08-21 | 2003-04-29 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists |
| WO2003000056A1 (en) | 2001-06-25 | 2003-01-03 | Inspire Pharmaceuticals, Inc. | Joint lubrication with p2y purinergic receptor agonists |
| WO2003039473A2 (en) * | 2001-11-06 | 2003-05-15 | Inspire Pharmaceuticals, Inc. | Method for treating or preventing inflammatory diseases |
| JP2006505585A (ja) * | 2002-10-18 | 2006-02-16 | モリケム メディシンズ， インコーポレイテッド | ランチビオティクスで眼乾燥症を処置する方法 |
| CA2565457A1 (en) * | 2004-05-06 | 2005-11-17 | Molichem Medicines, Inc. | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
| EP1753445A4 (en) * | 2004-05-06 | 2009-05-20 | Molichem Medicines Inc | TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS |
| US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
| US7851456B2 (en) * | 2005-06-29 | 2010-12-14 | Inspire Pharmaceuticals, Inc. | P2Y6 receptor agonists for treating lung diseases |
| US20070249556A1 (en) * | 2006-04-21 | 2007-10-25 | Brubaker Kurt E | Method of treating inflammation |
| JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び／又は治療用組成物 |
| WO2019112383A1 (ko) * | 2017-12-08 | 2019-06-13 | 윤주석 | 금속 미네랄 디아미네이트 및 이의 제조방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2122529A1 (de) * | 1971-05-06 | 1972-12-14 | Max Planck Gesellschaft zur Förde rung der Wissenschaften e V , 3400 Gottin gen | Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung |
| US3960840A (en) * | 1972-12-29 | 1976-06-01 | University Of Illinois Foundaton | Fluorescent derivatives of adenine-containing compounds |
| US4501729A (en) * | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
| DK0508687T3 (da) * | 1991-04-06 | 1996-02-05 | Astra Pharma Prod | ATP-analoger |
| FR2684299B1 (fr) * | 1991-12-02 | 1995-03-24 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride. |
| FR2677250B1 (fr) * | 1991-06-05 | 1995-01-20 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. |
| EP0517573A1 (fr) * | 1991-06-05 | 1992-12-09 | Synthelabo | Compositions pharmaceutiques pour le traitement des affections des voies respiratoires |
| US5292498A (en) * | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
| US5635160A (en) * | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| US5628984A (en) * | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
-
1996
- 1996-11-07 US US08/744,367 patent/US6159952A/en not_active Expired - Lifetime
-
1997
- 1997-10-21 WO PCT/US1997/018766 patent/WO1998019685A1/en active IP Right Grant
- 1997-10-21 AT AT97912761T patent/ATE249833T1/de not_active IP Right Cessation
- 1997-10-21 CA CA002271126A patent/CA2271126C/en not_active Expired - Lifetime
- 1997-10-21 KR KR10-1999-7004018A patent/KR100518066B1/ko not_active IP Right Cessation
- 1997-10-21 BR BR9714312-0A patent/BR9714312A/pt not_active Application Discontinuation
- 1997-10-21 AU AU49866/97A patent/AU744981B2/en not_active Expired
- 1997-10-21 CN CN97199444A patent/CN1115152C/zh not_active Expired - Lifetime
- 1997-10-21 DE DE69724991T patent/DE69724991T2/de not_active Expired - Lifetime
- 1997-10-21 EP EP97912761A patent/EP0941099B1/en not_active Expired - Lifetime
- 1997-10-21 NZ NZ335540A patent/NZ335540A/en unknown
- 1997-10-21 ES ES97912761T patent/ES2207723T3/es not_active Expired - Lifetime
- 1997-10-21 JP JP52141998A patent/JP2001505553A/ja active Pending
-
1999
- 1999-05-05 NO NO992197A patent/NO992197L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9714312A (pt) | 2000-05-02 |
| NO992197L (no) | 1999-07-05 |
| CN1115152C (zh) | 2003-07-23 |
| DE69724991T2 (de) | 2004-11-11 |
| CA2271126A1 (en) | 1998-05-14 |
| KR20000053094A (ko) | 2000-08-25 |
| ATE249833T1 (de) | 2003-10-15 |
| NZ335540A (en) | 2001-05-25 |
| ES2207723T3 (es) | 2004-06-01 |
| AU744981B2 (en) | 2002-03-07 |
| CN1236318A (zh) | 1999-11-24 |
| DE69724991D1 (de) | 2003-10-23 |
| WO1998019685A1 (en) | 1998-05-14 |
| US6159952A (en) | 2000-12-12 |
| EP0941099A1 (en) | 1999-09-15 |
| AU4986697A (en) | 1998-05-29 |
| JP2001505553A (ja) | 2001-04-24 |
| KR100518066B1 (ko) | 2005-09-28 |
| EP0941099B1 (en) | 2003-09-17 |
| CA2271126C (en) | 2008-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO992197D0 (no) | FremgangsmÕte for Õ behandle bronkitt med uridintrifosfater og relaterte forbindelser | |
| US5763447C1 (en) | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds | |
| WO1997035591B1 (en) | Method of treating ciliary dyskinesia with uridine triphosphates and related compounds | |
| DE69716255D1 (de) | Verfahren zur behandlung von mittelohrentzündung mittels uridintriphosphaten und verwandten mitteln | |
| NZ313864A (en) | Method of obtaining a mucous sample from the lung using triphosphate compounds | |
| DE69625906T2 (de) | Dinukleotide zur verwendung in der behandlung von lungenkrankheiten | |
| DE69431290D1 (de) | PULMONÄRE VERABREICHUNG DES LÖSLICHEN KOMPLEMENT-RECEPTORS TYP 1 sCR1 | |
| DK0734249T3 (da) | Hidtil ukendt og forbedret aminoglycosidformulering til aerosolisering | |
| ES2137371T3 (es) | Nuevos compuestos quimicos que tienen actividad de inhibicion de la pde-iv. | |
| MD1838G2 (ro) | Derivaţi de 5,6-diclorbenzimidazol, procedeu de obţinere a lor, compoziţie farmaceutică şi metodă de tratament sau de prevenire a infecţiei virotice herpetice | |
| DE69914084D1 (de) | Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen | |
| HU213677B (en) | Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them | |
| HUP9802142A2 (hu) | Na+/H+ -ioncsere inhibítorok alkalmazása a központi idegrendszer betegségeinek kezelésére és megelőzésére alkalmas gyógyszerkészítmények előállítására | |
| UA28922A (uk) | Спосіб лікування респіраторного дистрес-синдрому дорослих |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |